Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Evaluating the Effectiveness of an AI-Powered Physician Assistant in Improving Patients' and Physicians' Satisfaction in Anaesthesiology Clinics

31. juli 2026 oppdatert av: Dileep Kumar, Aga Khan University

Evaluating the Effectiveness of an AI-Powered Physician Assistant in Improving Patients' and Physicians' Satisfaction in Anaesthesiology Clinics of a Tertiary Care Hospital

This trial aimed to evaluate the effectiveness of an AI-Powered Physician Assistant in improving patients' satisfaction with the quality of care. It also aims to evaluate physicians' satisfaction with the integration of a Physician Assistant into their clinical workflows. The primary research question is

A. What is the effect of an AI-powered Physician Assistant on patients' satisfaction with their quality of care compared to the standard care?

The secondary questions are as follows:

B1. How satisfied are physicians with integrating an AI-powered physician assistant into their daily clinical workflows?

B2. Which factors are significantly associated with patient satisfaction regarding the AI-Powered Physician Assistant?

B3. Is there a statistically significant difference in mean consultation time per patient between those receiving AI-assisted care and those receiving only standard of careonly ?

Participants will be enrolled from pre-operative outpatient clinics, including patients attending clinic for anaesthetic clearance prior to surgery and consultant anaesthetists providing care.

Patients will serve as the unit of randomization and will be assigned to one of two study arms on each clinic day. On each clinic day, the first 8 eligible patients presenting for consultation will be randomly assigned to the intervention group or the control group in a 1:1 ratio. Intervention patients will proceed to a dedicated waiting room for structured digital intake via an AI platform (demographics, symptoms, history, clinical data) and receive AI-assisted care. Control group patients will undergo routine standard care protocols. The consultant physician will evaluate both arms during each clinic session, reviewing physician assistant-generated patient summaries and charts for patients in both the intervention and control groups.

Each patient will be asked to fill out the survey at the end of the consultation with the physician. The consultants will be requested to fill out a survey at the end of the day.

Studieoversikt

Status

Har ikke rekruttert ennå

Studietype

Intervensjonell

Registrering (Antatt)

180

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Sindh
      • Karachi, Sindh, Pakistan, 74800
        • Aga Khan University Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dileep Kumar

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Beskrivelse

Patients and Patients' Proxies

Inclusion Criteria:

  • Consent to participate
  • Age 18 years and above
  • Initial patients
  • Possession of a phone
  • Read and write Urdu and/or English

Exclusion Criteria:

  • Emergency Care patients
  • Follow-up patients

Physicians:

Inclusion Criteria

  • Attending or Consultant Physician
  • Consent to participate
  • Workflow integrated with AI Assistant

Exclusion Criteria

- Residents and Senior Medical Officers

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: AI-Assisted Care
The patients in this arm will receive AI-assisted care in addition to the standard care. The AI platform will take the patient's history, and then the patient will talk to the consultant as part of the routine flow.
The study participant allocated to the intervention arm will interact with the AI-physician assistant application before they consult with the physician. The application will collect medical history of the patient. This will then be followed by an AI-generated clinical summary, which their physicians will receive before the consultation begins. Physicians will review this summary and ask further questions of patients if required. Any additions and changes in the patient's history will also be made. Physicians will subsequently conduct a physical examination of the patient. After this, the physician will be able to view AI- and guideline-based suggestions for the patient's assessment and pre-operative management. The recommendations can be selected, modified, or not used as per the physician's expertise. All additions within the application can be either typed manually or verbalised via an AI-assisted scribe within the application.
Ingen inngripen: Standard Care
The patients in this arm will receive standard care. The standard of care for our study is what is usually applied in Anaesthesiology outpatient clinics, with consultants seeing the patients after the resident.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Patient Satisfaction and Outpatient Experience Score (Adapted NHS Outpatient Survey - Patient Questionnaire)
Tidsramme: From enrollment to the end of the study, for each patient, for 8 weeks

Patient satisfaction will be evaluated across two domains: (1) effective utilization of waiting time and (2) receipt of patient-centered care during the outpatient visit.

Evaluated post-consultation using a structured survey adapted from the NHS Outpatient Survey: Section A (Wait Time): Wait duration (A1) and wait time utility (A2). Section B (Doctor Interaction): Patient-centered care, consultation duration, listening, and clarity (B2-B7). Section C (AI Assistant - Intervention Arm Only): Perceived listening, trust, and privacy (C1-C6). Section D (Overall Impression): Respect, dignity, and care- quality (D1-D3).

Ordinal items are assigned numerical scores to calculate a composite mean score and domain sub-scores (range: 1.0-5.0). Higher scores indicate greater satisfaction.

From enrollment to the end of the study, for each patient, for 8 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Daily Physician Satisfaction and Workflow Efficiency Score (End-of-Day Physician Survey)
Tidsramme: From enrollment to the end of the study, for each physician, for 8 weeks

Physician satisfaction and workflow efficiency will be evaluated using an end-of-day survey administered to physicians whose patients were recruited into the study. Evaluated using a two-part structured questionnaire:

Section 1 (Comparative Workflow): Binary comparisons across 5 domains (consultation duration, patient engagement, documentation efficiency, cognitive workload, and focus on patient care), with 3-point follow-up sub-questions for favorable intervention responses.

Section 2 (Intervention Utility): 6 intervention-specific items assessing accuracy/trust, workflow efficiency, workload relief, and overall satisfaction (5-point ordinal scales; 1 = Strongly Disagree, 5 = Strongly Agree).

Daily composite mean scores are calculated from Sections 1 and 2 (range: 1.0-5.0). Higher scores indicate greater satisfaction.

From enrollment to the end of the study, for each physician, for 8 weeks
Total Physician Consultation Duration (Stopwatch Timestamps)
Tidsramme: From enrollment to the end of the study, for each patient, for 8 weeks

Evaluates total physician consultation duration (in minutes) for each patient during their outpatient clinic encounter.

Consultation time refers to the active time spent by the physician while the patient is inside the consultation room. It encompasses the time taken to inquire about symptoms, conduct physical examinations, prescribe treatments, and provide counseling.

Duration is objectively measured in minutes using manual stopwatch timestamps, initiated the moment the patient enters the consultation room and concluded when the patient departs.

Mean total consultation times will be calculated per patient and compared between the intervention and standard care arms. Lower or more optimized consultation durations reflect enhanced workflow efficiency.

From enrollment to the end of the study, for each patient, for 8 weeks

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Process flow evaluation outcome - Mean Queuing Time (Timestamp Tracking)
Tidsramme: From enrollment to the end of the study, for each patient, for 8 weeks

Recorded using objective timestamps across two sequential intervals:

Interval 1: Completion of counter registration to initiation of vital signs measurement.

Interval 2: Completion of vital signs measurement to patient entry into the physician consultation room.

Intervals are combined into a single aggregated total queuing time per patient visit. Lower mean queuing times indicate improved operational workflow efficiency.

From enrollment to the end of the study, for each patient, for 8 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Dileep Kumar, Aga Khan University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

30. august 2026

Primær fullføring (Antatt)

30. oktober 2026

Studiet fullført (Antatt)

30. oktober 2026

Datoer for studieregistrering

Først innsendt

28. juli 2026

Først innsendt som oppfylte QC-kriteriene

31. juli 2026

Først lagt ut (Faktiske)

3. august 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

3. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

31. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

The plan is to publish the study, and informed consent has been obtained from each participant. Each participant's data will be de-identified at the source level for both the application and survey.

Tilgangskriterier for IPD-deling

Through Publication Only

IPD-deling Støtteinformasjonstype

  • SEVJE
  • CSR

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere